About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 272 record(s)
Nothing to report this month
Organization: RCMP External Review Committee
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: RCMP External Review Committee
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: RCMP External Review Committee
Req # A-2022-01918
Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.Organization: Patented Medicine Prices Review Board Canada
September 2022
Nothing to report this month
Organization: RCMP External Review Committee
Nothing to report this month
Organization: Toronto Port Authority
Req # A-2021-10763
Copies of all emails to/from/cc'ing all Directors from May 21, 2021 to May 30, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022
Req # A-2021-10773
Copies of all emails sent by external sources to the PMPRB and Douglas Clark from May 22, 2021 to June 14, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022